Af­ter months of hunt­ing for po­ten­tial buy­ers of mul­ti­ple man­u­fac­tur­ing sites in Ger­many, BioN­Tech said it will close these fa­cil­i­ties af­ter be­ing un­able to lock...

A Cal­i­for­nia start­up has raised a $251 mil­lion Se­ries D to ad­vance phar­ma­ceu­ti­cal man­u­fac­tur­ing in space, long seen as the next fron­tier for drug de­vel­op­ment...

SK pharmte­co plans to spend at least $200 mil­lion on build­ing out its de­vel­op­ment and man­u­fac­tur­ing in­fra­struc­ture over the next five years, which is ex­pect­ed...

The White House­'s Of­fice of Man­age­ment and Bud­get (OMB) is ask­ing for more in­for­ma­tion on the do­mes­tic pro­duc­tion of 86 es­sen­tial med­i­cines, such as the...

The many No­vo in­vestors hop­ing for a trans­for­ma­tive deal will have to con­tent them­selves with an­oth­er small de­vel­op­ment pact.

The Swedish biotech Nanexa saidThurs­day...